Renal Cancers Completed Phase Trials for Alemtuzumab (DB00087)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00073879Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationTreatment